Skip to content

Advertisement

  • Research article
  • Open Access

Local control of polymicrobial infections via a dual antibiotic delivery system

  • 1, 2Email author,
  • 1,
  • 3,
  • 3 and
  • 1
Journal of Orthopaedic Surgery and Research201813:53

https://doi.org/10.1186/s13018-018-0760-y

  • Received: 15 September 2017
  • Accepted: 7 March 2018
  • Published:

Abstract

Background

Contaminated traumatic open orthopedic wounds are frequently complicated by polymicrobial contamination and infection. In high-risk wounds, the standard of care comprises debridement and irrigation combined with antibiotics which can be applied directly or combined with systemic antibiotics. Recently, bioabsorbable chitosan sponges have been shown to be an effective single-agent delivery device for local antibiotics with and without negative pressure wound therapy (NPWT). Severely contaminated orthopedic wounds, however, are often complicated by polymicrobial infections, necessitating multiple antibiotic agents. As such, the purpose of this study was to determine if a chitosan sponge would provide a suitable delivery vehicle for multiple antibiotics for the treatment of a polymicrobial infection in a large animal polytraumatic extremity wound model.

Methods

A complex polytraumatic extremity wound was created in 11 adult male Boer goats. Each wound was contaminated with a bioluminescent strain of S. aureus (1 ml of 108 colony forming units/ml) and of P. aeruginosa (1 ml of 108 CFU/ml) which are genetically engineered to allow quantification with a photon-counting camera. Six hours following initial wound creation and contamination, wounds were debrided and irrigated with low-pressure normal saline. The animals were randomized into one of two treatments: wet-to-dry dressings alone or a commercially available chitosan sponge loaded with 1 g vancomycin and 1.2 g of tobramycin. Each animal was then recovered and reimaged 48 h later for total bacteria content; tissue samples were taken from the wound bed to determine relative bacterial colonization.

Results

All animals in the chitosan sponge group saw significant reductions in overall bacterial load of S. aureus and P. aeruginosa (p = 0.001). The bioluminescence was also significantly reduced compared to the wet-to-dry dressing group (p = 0.0001). Furthermore, whereas the antibiotic sponge group displayed near complete eradication of bacteria, the wounds treated with the wet-to-dry dressings alone displayed a significant 2-log increase in total bacteria at 48 h p = 0.0001). S. aureus was the predominant species found in the wounds, comprising 95 and 99% of all bacteria found in the chitosan sponge and wet-to-dry, respectively.

Conclusion

Dual antimicrobial therapy loaded in a chitosan sponge is an effective way to reduce polymicrobial infections traumatic extremity wound.

Keywords

  • Chitosan
  • Antimicrobial
  • Polymicrobial

Background

Traumatic, open orthopedic wounds are associated with high rates of patient-related morbidity and costs due to their mechanism of injury and prevalence of wound complications secondary to infection [15]. Specifically, high-energy lower extremity fractures have infection rates around 20% but have been reported as high as 52% [14]. The current standard of care for these injuries is debridement and irrigation combined with systemic antibiotics. Previous studies have shown that, amongst other factors, time to surgical debridement, time to definitive soft tissue coverage, and time to antibiotics correlate with infection rates following traumatic orthopedic trauma [69].

Many injuries are not amenable to the systemic delivery of antibiotics due to the severity of the soft tissue zone of injury and corresponding microvascular and macrovascular injuries. As such, a strong interest in local antibiotic delivery mechanisms by direct local application of antibiotic powders or via antibiotic carriers that allow a slower release of antibiotic over time is gaining in popularity [1016]. Previous animal studies have shown that commercially available absorbable chitosan sponges are suitable carriers for single-agent antibiotic delivery and allow for reductions in bacteria with or without negative pressure wound therapy adjuncts when applied to a contaminated wound [10, 17]. These bioabsorbable chitosan sponges are capable of time-releasing antibiotics directly into a wound bed while also acting as a space filler [10, 1720]. However, many traumatic orthopedic wound infections are polymicrobial and may require multiple antibiotics for adequate treatment. The purpose of this study was to determine whether chitosan sponges provide a suitable delivery mechanism for the local application of dual antibiotic therapy in the setting of a polymicrobial infection following a simulated traumatic extremity wound.

Methods

This study was conducted in compliance with the Animal Welfare Act, the implementing Animal Welfare Regulations, and in accordance with the principles of the Guide for the Care of and Use of Laboratory Animals. All procedures were performed in a laboratory accredited by the Association and Accreditation of Laboratory Animal Care following a protocol approved by the Institutional Animal Care and Use Committee of the US Army Institute of Surgical Research.

A complex polytraumatic extremity wound was created in 11 adult male Boer goats (44 kg ± 2.7SEM, K Bar Livestock LLC, Sabinal, TX) to simulate a severe traumatic orthopedic related injury [10, 21]. On the day of surgery, animals received glycopyrrolate (0.01 mg/kg, SC) and carprofen (4.4 mg/kg, SC) approximately 1 h before surgery. Anesthesia was induced by a combination of ketamine hydrochloride (2.75 mg/kg) and midazolam (0.25 mg/kg), given intravenously. Anesthesia was maintained with 1–3% isoflurane via endotracheal intubation. A caudal epidural injection of morphine (0.1 mg/kg) was given at the initial surgery. A trapezoidal full thickness skin flap starting at the tibia tubercle and 8 cm in length, 5 cm wide proximally, and 3 cm distally was made in a single lower hind leg. To replicate a severe musculoskeletal injury, 13 g of anterior tibialis was excised to create a volumetric muscle loss injury; periosteum was removed leaving a 6-mm-wide strip; a 12-mm circumferential unicortical defect was created in the anterolateral tibia; a thermal burn on the bone, periosteum, muscle, fascia, and skin was made using electrocautery; and a 1 × 4-cm freeze injury was made using a liquid nitrogen cooled metal bar held directly on the surrounding musculature in two 30 s intervals.

Following creation of the severe orthopedic injury, each wound was contaminated with 108 colony forming units (CFU) each of bioluminescent strains of Staphylococcus aureus (Xenogen 36; Caliper Life Science, Hopkinton, MA) and Pseudomonas aeruginosa (lux), which are genetically engineered to allow quantification with a photon-counting camera as they release photons as a part of normal respiration. Bioluminescent bacteria emit light in proportion to their number, therefore allow noninvasive quantification using an external sensor. These bacteria were independently spread evenly over the entire wound bed using a cotton-tipped applicator. Each wound was then dressed with a sterile compressive, impermeable dressing. The animals were recovered in their cage until irrigation and debridement (I&D). Animals received once daily carprofen (4.4 mg/kg SC) for pain throughout the course of the study.

Baseline data was collected 6 h following initial wound creation and contamination. Each goat was again placed under general anesthesia in a light-free chamber that allows quantification of bacterial photon emission using a photon-counting camera (Charge Couple Device Imaging System Model C2400, Hamamatsu Photonics, Inc., Hamamatsu City, Japan). This camera allows for a quantitative and qualitatively determination of the amount and location of bacteria within a wound at the time of imaging. Briefly, a bright field photo was acquired of the area to establish wound borders. Then a photon image was acquired using the photon-counting camera which provides a visual representation and quantitative concentrations of photons within the area. The bright field and photon images were overlaid to create the region of interest and bioluminescence acquired using the Wasabi (Hamamatsu Photonics) interface software. After baseline bioluminescence was determined, each wound was irrigated with 9 l of low-pressure normal saline combined with mechanical soft tissue debridement that removed approximately 75% of the bacteria from the wound.

Each animal was randomly assigned to one of two treatment groups: the control group received a standard wet-to-dry dressings (WTD; n = 6) and the experimental group received a local treatment with a commercially available chitosan sponge (Sentrex Biosponge, Bionova Medical Inc., Germantown, TN) loaded with two clinically relevant antibiotics (CH-ABX; n = 5). The WTD dressing used sterile gauze and saline placed into the wound and covered with a sterile, impermeable dressing. The CH-ABX dressing was composed of a prepackaged 10 × 15-cm chitosan sponge (Sentrex Biosponge, Bionova Medical, Germantown, TN) capable of absorbing 0. 4 ml/cm2. The chitosan sponge was rehydrated with 60 ml of 0.9% normal saline mixed with 1 g vancomycin and 1.2 g tobramycin. The impregnated sponge was then placed directly into the contaminated wound and covered with an impermeable dressing. Each dressing was left in place until the end of the study.

All animals were anesthetized and euthanized 48 h after the initial time of contamination and bacteria again quantified using a photon-counting camera [10, 21]. Wound cultures were taken from the wounds systematically from the 12, 3, 6, and 9 o’clock positions within each wound. An additional culture was taken from an area identified as having the highest concentration of bioluminescence at the time of final imaging. Bacteria from these biopsies were then enumerated by plating serial dilutions of tissue homogenate supernatant onto three bacterial growth media: a non-selective 5% sheep blood agar, a CHROMagar that preferentially grows S. aureus, and a Pseudomonas Isolation agar that preferentially allows for P. aeruginosa growth [22]. The CFU were averaged across the wound and were normalized to tissue mass to determine the bioburden of the wound. Bioburden composition was determined as the ratio of S. aureus or P. aeruginosa to the total number of bacteria within the wound.

Exclusion criteria

Animals were excluded from the study completely if they met one of the following criteria: dressing fell off before completion of the study, tibia or adjacent bones fractured due to surgical complications, animals were euthanized prematurely due to a failure to thrive, animals were found dead prior to completion of study, and baseline bacteria quantities were significant outliers based on Grubb’s test for outliers.

Statistical methods

All data were analyzed using descriptive statistics, a t test, or a two-way ANOVA with Sidak’s multiple comparison test as appropriate. Significance was set at p < 0.05. A Grubb’s test was used to detect outliers. All data are presented as mean ± standard error of the mean.

Results

An overall decrease in bacteria was detected when the CH-ABX treatment was applied in lieu of the standard WTD dressing (Fig. 1). Within the control WTD dressing group, one animal died prior to completion of the study of undetermined causes, one animal was euthanized due to a fracture of the tibia shaft during wound creation, and an additional animal was found to be an outlier (Grubb’s test for outliers) and excluded completely from the study analysis as it displayed luminescence of 1000 fold of baseline. Using photoluminescence, it was determined that both groups had similar levels of bacterial contamination after the initial debridement, 6 h after contamination (controls 21.83 ± 4.89% baseline, CH-ABX 24.98 ± 3.99% baseline) (Fig. 2). All animals treated with CH-ABX survived and showed significant reduction in bacteria (0.09 ± 0.06% baseline, p < 0.001) where a near 100% bacterial reduction was observed (Fig. 2) between the post-debridement and the 48-h post-inoculation points. Compared to the WTD dressing control group, the CH-ABX significantly reduced the bacteria (p < 0.0001). At the time of final imaging, control animals showed a significant 2-log increase (83.60 ± 8.95%, p < 0.0001) in bacteria at 48 h (Fig. 2). Bacterial enumeration showed that 98.9 ± 1.1 and 94.7 ± 5.3% of bacteria cultured from the WTD and CH-ABX, respectively, were S. aureus (Table 1).
Fig. 1
Fig. 1

Representative black and white images with bioluminescent overlay. Higher intensity regions (red) correlate with increased bacteria load. Images from the left to right represent pre-debridement at 6 h from primary surgery, immediate post-debridement and irrigation with removal of approximately 75% of bacteria, and 48 h following primary surgery and inoculation. WTD wet-to-dry dressing, CH-ABX chitosan sponge with antibiotics

Fig. 2
Fig. 2

Percent bacteria remaining compared to initial imaging as found by bioluminescence. Baseline values are normalized to 100%, and each repeated measure is compared to its own baseline. A two-way ANOVA with a Sidek’s multiple comparison test was used. P values within the chart are bolded within the table and are of special interest

Table 1

Results of wound cultures on bacteria specific media

 

Animals with detectable S. aureus

Percent of total enumerated

Animals with detectable P. aeruginosa

Percent of total enumerated

WTD

3/3

98.9*

3/3

1.1

CH-ABX

4/5

94.7*

1/5

5.3

*Represents significant differences at p < 0.0001 using t test comparing recovered bacteria percentage of S. aureus to P. aeruginosa within the same treatment type

Discussion

Using an established contaminated traumatic orthopedic wound model, this study found that the application of a chitosan sponge containing vancomycin and tobramycin decreased bacterial burden in a polymicrobial wound. Furthermore, the antibiotic loaded chitosan sponges released the antibiotics at sufficient doses to achieve near complete eradication of bacteria 48 h following application. These treatment effects were not seen in the control group that had 2-log increase in bacterial counts when compared to post-debridement.

Prior studies have demonstrated that high-dose antibiotics are effective at treating and preventing infection in contaminated and high-risk orthopedic wounds [1014, 16]. Specifically, a chitosan sponge has been shown to be an effective carrier of a single antibiotic against a single bacterial agent in previous studies using this model [10]. These studies have also shown that antibiotic levels above the MIC for S. aureus and P. aeruginosa are achievable when antibiotics are delivered via a chitosan sponge in both in vitro and animal studies [17, 19, 20]. This current study displayed similar results in a larger animal polymicrobial traumatic orthopedic wound model as bacteria were nearly entirely eradicated from the wounds treated with a vancomycin- and tobramycin-loaded chitosan sponge. This study also corroborates the use of a chitosan sponge for the use of polymicrobial infections and/or contaminated fracture care where a polymicrobial environment is expected. Furthermore, unlike antimicrobial loaded PMMA beads where the antimicrobial effect is limited to its immediate surroundings, the chitosan sponge is able to deliver a high dose of antibiotic over a large area within the complex wound. This may be particular of importance in those unstable patients who require repeated formal debridement and irrigation or in those patients who are not hemodynamically stable enough to undergo a thorough initial operative debridement. This delivery mechanism may also be useful in those cases where a negative pressure wound dressing is used as it has been shown to be more effective than PMMA beads or a negative pressure wound dressing alone [23].

This study has several limitations inherent to its preclinical animal model design. Most notably, this study only used a single treatment group with an untreated control. While this does impart a degree of potential bias in our results, this study was performed as a follow-up of previous work at our institution that used the same bacteria and model that has evaluated several other treatment modalities with reproducible success [10, 21, 23]. Repeating this study in successfully treated prior groups is not the best stewardship of laboratory animals and funding. The number of animals used in this study is small; however, the results are sufficiently dichotomous and statistically significant to the degree that continuing with additional animals was not required. This study employed a systematic sampling pattern in order to decrease any sampling bias that would occur with directed samples or random samples alone. While more stringent, this method does cause some degree of detection error and does not address specific areas of injury within the wound. As such, imaging directed samples were obtained at areas of highest bioluminescence in order to decrease our detection error and increase the probability that we would successfully obtain qualitative data. Lastly, this study only evaluated the treatment effects at 48 h. Prior work has shown that the majority of the antibiotic is released within the first 72 h [20]. As such, the remaining sponge may prove to be a nidus for infection if not removed. However, this is not unlike PMMA where the carrier necessitates removal in subsequent surgeries and does not allow for definitive management [24, 25].

Conclusion

This study suggests that the chitosan sponge is an effective dual antibiotic carrier that can be used effectively to combat a persistent infection in a polymicrobial-infected traumatic orthopedic wound. The treatment effect seen in this study is consistent with previous studies evaluating single-agent treatment and may prove to be a more effective carrier mechanism than antibiotic depots such as bone cement. While this study does provide promising results, further studies evaluating this carrier in comparison to other topically applied antimicrobials may be warranted.

Abbreviations

CFU: 

Colony-forming units

CH-ABX: 

Chitosan sponge with antibiotics

CHROMagar: 

Chromographic agar

NPWT: 

Negative pressure wound therapy

P. aeruginosa

Pseudomonas aeruginosa

PMMA: 

Polymethylmethacrylate

S. aureus

Staphylococcus aureus

WTD: 

Wet-to-dry

Declarations

Acknowledgements

The authors would like to thank the animal research technicians and Veterinary Support Branch of the US Army Institute of Surgical Research for their technical expertise and assistance during this project.

Funding

This work was partially funded by the Department of Defense award number W81XWH-12-2-0020. The funding body had no role in the design of the study, the collection of data, the analysis of results, or the interpretation of data.

Availability of data and materials

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request, taking into account any confidentiality.

Disclaimer

The opinions or assertions contained herein are the private views of the author and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.

Authors’ contributions

DJT contributed to the study design, execution, data analysis, and final drafting of the manuscript. SMS contributed to the study design, protocol approval, data analysis, and manuscript drafting. JAJ obtained the funding and contributed to the study design and manuscript drafting. WOH obtained the funding and contributed to the study design and manuscript drafting. JCW obtained the funding and contributed to the study design, data analysis, and final drafting of the manuscript. All authors read and approved the final manuscript.

Ethics approval

All animal procedures were approved by the Institutional Animal Care and Use Committee of the US Army Institute of Surgical Research, Fort Sam Houston, TX, and were conducted in compliance with the Animal Welfare Act, the implementing Animal Welfare Regulations, and the principles of the Guide for the Care and Use of Laboratory Animals.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
United States Army Institute of Surgical Research, 3855 Roger Brooke Drive, Fort Sam Houston, San Antonio, TX 78234, USA
(2)
Department of Orthopaedics and Rehabilitation, San Antonio Military Medical Center, 3855 Roger Brooke Drive, Fort Sam Houston, San Antonio, TX 78234, USA
(3)
Herff College of Engineering, 328D Engineering Technology Building, Memphis, TN 38152, USA

References

  1. Gustilo RB, Mendoza RM, Williams DN. Problems in the management of type III (severe) open fractures: a new classification of type III open fractures. J Trauma. 1984;24:742–6.View ArticlePubMedGoogle Scholar
  2. Gustilo RB, Anderson JT. Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses. J Bone Joint Surg Am. 1976;58:453–8.View ArticlePubMedGoogle Scholar
  3. Harris AM, Althausen PL, Kellam J, et al. Complications following limb-threatening lower extremity trauma. J Orthop Trauma. 2009;23:1–6.View ArticlePubMedGoogle Scholar
  4. Keeling JJ, Gwinn DE, Tintle SM, et al. Short-term outcomes of severe open wartime tibial fractures treated with ring external fixation. J Bone Joint Surg Am. 2008;90:2643–51.View ArticlePubMedGoogle Scholar
  5. Thakore RV, Greenberg SE, Shi H, et al. Surgical site infection in orthopedic trauma: a case-control study evaluating risk factors and cost. J Orthop Trauma. 2015;6(4):220–6.Google Scholar
  6. Harley BJ, Beaupre LA, Jones CA, et al. The effect of time to definitive treatment on the rate of nonunion and infection in open fractures. J Orthop Trauma. 2002;16:484–90.View ArticlePubMedGoogle Scholar
  7. Lack WD, Karunakar MA, Angerame MR, et al. Type III open tibia fractures: immediate antibiotic prophylaxis minimizes infection. J Orthop Trauma. 2015;29:1–6.View ArticlePubMedGoogle Scholar
  8. Patzakis MJ, Wilkins J. Factors influencing infection rate in open fracture wounds. Clin Orthop Relat Res. 1989;243:36–40. PMID: 2721073Google Scholar
  9. Penn-Barwell JG, Murray CK, Wenke JC. Early antibiotics and debridement independently reduce infection in an open fracture model. J Bone Joint Surg Br. 2012;94:107–12.View ArticlePubMedGoogle Scholar
  10. Stinner DJ, Noel SP, Haggard WO, Watson JT, Wenke JC. Local antibiotic delivery using tailorable chitosan sponges: the future of infection control. J Orthop Trauma. 2010;24:592–7.View ArticlePubMedGoogle Scholar
  11. Hovis JP, Montalvo R, Marinos D, Joshi M, Shirtliff M, Manson TT, O'Toole RV. Intraoperative Vancomycin Powder Reduces Staphylococcus aureus Surgical Site Infections and Biofilm Formation on Fixation Implants in a Rabbit Model. J Orthop Trauma. 2018 Epub ahead of print].Google Scholar
  12. Ostermann PA, Seligson D, Henry SL. Local antibiotic therapy for severe open fractures. A review of 1085 consecutive cases. J Bone Joint Surg Br. 1995;77:93–7.View ArticlePubMedGoogle Scholar
  13. Henry SL, Ostermann PA, Seligson D. The prophylactic use of antibiotic impregnated beads in open fractures. J Trauma. 1990;30:1231–8.View ArticlePubMedGoogle Scholar
  14. Hanssen AD. Local antibiotic delivery vehicles in the treatment of musculoskeletal infection. Clin Orthop Relat Res. 2005;437:91–6. PMID: 16056032View ArticleGoogle Scholar
  15. Singh K, Bauer JM, LaChaud GY, Bible JE, Mir HR. Surgical site infection in high-energy peri-articular tibia fractures with intra-wound vancomycin powder: a retrospective pilot study. J Orthop Traumatol. 2015;16(4):287–91.View ArticlePubMedPubMed CentralGoogle Scholar
  16. Tennent DJ, Shiels SM, Sanchez CJ, Niece KL, Akers KS, Stinner DJ, Wenke JC. Time-dependent effectiveness of locally applied vancomycin power in a contaminated orthopaedic wound model. J Orthop Trauma. 2016;30(10):531–7.View ArticlePubMedGoogle Scholar
  17. Jennings JA, Beenken KE, Parker AC, Smith JK, Courtney HS, Smeltzer MS, Haggard WO. Polymicrobial biofilm inhibition effects of acetate-buffered chitosan sponge delivery device. Macromol Biosci. 2016;16(4):591–8.View ArticlePubMedGoogle Scholar
  18. Wedmore I, McManus JG, Pusateri AE, Holcomb JB. A special report on the chitosan––based hemostatic dressing: experience in current combat operations. J Trauma. 2006;60:655–8.View ArticlePubMedGoogle Scholar
  19. Smith JK, Moshref AR, Jennings JA, Courtney HS, Haggard WO. Chitosan sponges for local synergistic infection therapy: a pilot study. Clin Orthop Relat Res. 2013;471(10):3158–64.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Noel SP, Courtney HS, Bumgardner JD, Haggard HO. Chitosan sponges to locally deliver amikacin and vancomycin: a pilot invitro evaluation. Clin Orthop Relat Res. 2010;468(8):2074–80.View ArticlePubMedPubMed CentralGoogle Scholar
  21. Svoboda SJ, Bice TG, Gooden HA, Brooks DE, Thomas DB, Wenke JC. Comparison of bulb syringe and pulsed lavage irrigation with use of a bioluminescent musculoskeletal wound model. J Bone Joint Surg Am. 2006;88:2167–74.PubMedGoogle Scholar
  22. Gailot O, Wetsch M, Fortineau N, Berche P. Evaluation of CHROMagar Staph. Aureus, a new chromogenic medium for isolation of presumptive identification of Staphylococcus aureus from human clinical specimens. J Clin Microbiol. 2000;38(4):1587–91.Google Scholar
  23. Rand BCC, Wenke JC. An effective negative pressure wound therapy-compatible local antibiotic delivery device. J Orthop Trauma. 2017;31(12):631–5.View ArticlePubMedGoogle Scholar
  24. Neut D, van de Belt H, van Horn JR, van der Mei HC, Busscher HJ. Residual gentamicin-release from antibiotic-loaded polymethylmethacrylate beads after 5 years of implantation. Biomaterials. 2003;24(10):1829–31.View ArticlePubMedGoogle Scholar
  25. Neut D, van de Belt H, Stokroos L, van Horn JR, van der Mei HC, Busscher HJ. Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. J Antimicrob Chemother. 2001;47(6):885–91.View ArticlePubMedGoogle Scholar

Copyright

Advertisement